icct stock: iCoreConnect (ICCT) company guide

This guide explains icct stock — the ticker for iCoreConnect, Inc. — covering company background, products, recent corporate actions (including the Dec 23, 2024 reverse split), market metrics, risk...

2024-07-04 05:43:00

By ChainSync Analyst

Article rating

4.4

109 ratings

Bitget offers a variety of ways to buy or sell popular cryptocurrencies. Buy now!

A welcome pack worth 6200 USDT for new users! Sign up now!

ICCT (iCoreConnect Inc.) — stock

icct stock refers to the publicly traded shares of iCoreConnect, Inc., a U.S.-based provider of HIPAA‑compliant cloud software and services for healthcare organizations. This entry summarizes company background, products, financial and market data, recent corporate actions, risks, and where investors and researchers can verify facts. Note: icct stock is a micro‑cap / penny stock and is not a cryptocurrency or token.

Company overview

icct stock represents iCoreConnect, Inc., a technology company focused on delivering cloud-based, HIPAA-compliant software-as-a-service (SaaS) solutions to healthcare providers. The company provides digital tools intended to streamline clinical workflows, e-prescribing, secure messaging, controlled substance monitoring, billing support, and related services for physician practices, clinics, and other healthcare entities.

Headquarters and founding: iCoreConnect is U.S.-based; public profiles and filings indicate the company was established to develop healthcare-focused communication and transaction systems. For the latest executive addresses and corporate details, consult the company’s investor relations and SEC filings.
Primary markets: small-to-medium medical practices, pharmacies, and healthcare organizations in the U.S. healthcare market.
Positioning: iCoreConnect emphasizes HIPAA compliance and cloud hosting as key differentiators for healthcare customers that require secure data handling.

Products and services

icct stock's underlying business centers on a suite of cloud products and services. Key product lines reported in filings and vendor profiles include:

iCoreRx — an e-prescribing platform aimed at electronic prescriptions and prescription history management.
iCorePDMP — integrated access to prescription drug monitoring program (PDMP) data to help providers check controlled substance histories.
iCoreExchange — secure communications and data exchange tooling for providers and pharmacies.
iCoreCloud — cloud hosting and backup services for healthcare data with HIPAA-focused controls.
iCorePay — payment processing and transaction support tied to clinical billing and patient payments.
iCoreCodeGenius — coding assistance and clinical documentation tools that help with billing and compliance.

Each product is designed to serve healthcare workflows: prescription routing, secure messaging, PDMP checks, data storage and backup, payments, and coding support. These product names and roles are drawn from company profiles, filings and market-data summaries.

Business model

iCoreConnect operates primarily on a SaaS and transaction-fee model. Typical revenue drivers reported by market-data providers and filings include:

Subscription fees: recurring subscription revenue for access to cloud-hosted applications and services.
Transaction fees: per-transaction charges tied to e-prescribing or payment processing flows.
Professional services / setup: one-time fees for onboarding, integrations, and custom work.
Ancillary services: support, hosting, backups and optional add-ons.

The business model is typical for small healthcare SaaS firms: emphasis on recurring revenue, with churn and customer acquisition being key operating concerns.

Corporate history and milestones

This section highlights notable corporate events relevant to icct stock. Editors should verify dates and details against SEC filings and the company’s press releases.

Founding and development: iCoreConnect evolved into a public company offering healthcare SaaS products.
Public listing and trading: the company’s equity trades under the ticker ICCT in U.S. market data feeds; depending on data vendors the stock may be quoted on Nasdaq or OTC reporting feeds.
Reverse stock split: As reported by market sources, iCoreConnect implemented a reverse stock split effective December 23, 2024. (See corporate filings and market notices for the definitive mechanics and ratio.)
2025 corporate actions: market coverage reported financing events, loan agreements, and at times trading halts and resumptions during 2025. These items are summarized below and should be cross‑checked against 8‑K filings.

Recent corporate actions (examples)

Reverse split (Dec 23, 2024): As of Dec 23, 2024, several market-data sources reported that iCoreConnect completed a reverse split intended to consolidate shares outstanding. Refer to the company’s official filing for the exact split ratio and effective date.
Trading halts and resumptions (2025): As reported in 2025 market coverage, icct stock experienced trading halts and subsequent resumptions tied to pending disclosures and financing arrangements. Specific dates and reasons vary by incident and are available in SEC filings and market notices.
Financing and loan agreements (2025): Several small-cap data outlets noted reported financings or loan agreements in 2025. Those agreements may have included convertible instruments, promissory notes or equity-linked financing reported in company disclosures.

All the items above should be confirmed with the company’s SEC filings and press releases for legal and timing precision.

Stock market information

Ticker symbol: ICCT (commonly referenced as icct stock in market commentary).
Quoting venues: Market data providers list ICCT under Nasdaq or OTC reporting feeds depending on vendor; quotes may show as Nasdaq/OTC in various aggregators. Always check the quote convention on your chosen data platform.
Classification: icct stock is classified as a micro‑cap / penny stock by most data providers, reflecting low share price levels and a small market capitalization.

Trading history and price performance

icct stock has exhibited notable volatility typical of micro‑cap equities. Market histories show large intraday and multi‑session percentage swings, sometimes driven by thin liquidity, small float, or event-driven news such as financing announcements, stock splits, or trading halts. As of mid‑2025, historical price series indicate episodes of dramatic moves from low single-digit cents to larger intraday variations.

Key market metrics

Market capitalization: Market-data summaries reported market caps in the low millions (USD) as of mid‑2025. For example, multiple data vendors listed market cap figures that varied across feeds; readers should use the date-stamped metric on their chosen vendor and cross-check SEC disclosures for share count confirmation.
Revenue and profitability: Publicly reported revenue for trailing periods was roughly in the ~$10–11 million range, with net losses reported in recent 12-month periods. These figures are vendor‑reported aggregates; use the company’s 10‑K / 10‑Q filings for authoritative numbers.
Liquidity and average daily volume: icct stock commonly shows low average daily volume relative to larger-cap equities, producing potentially wide bid-ask spreads and price impact from modest trade sizes.

Corporate actions affecting the share count

Key events that materially change shares outstanding include reverse stock splits, equity issuances associated with financing, and conversion of debt or convertible instruments into common stock. The December 23, 2024 reverse split materially altered the per-share math; subsequent 2025 financing events reported by market coverage may have introduced dilution. Verify exact shares outstanding and any post‑period adjustments in the company’s most recent filings.

Financial performance

iCoreConnect’s financial profile combines modest revenue with recurring net losses and limited liquidity metrics typical for micro‑cap tech firms.

Revenue: Market-data sources and company summaries placed trailing revenue in the neighborhood of $10–11 million for the most recent 12‑month window reported by data vendors as of mid‑2025.
Profitability: The company has reported operating losses and net losses in recent reporting periods; net loss magnitudes were material relative to revenue, according to vendor summaries.
Cash and debt: Filings indicate limited cash reserves and some debt or financing obligations that management disclosed as part of financing events in 2025. Precise figures should be taken from the latest 10‑Q or 10‑K.

Selected financials (summary table description)

Below is a description of the kind of table editors should include; numeric values must be dated and sourced to filings:

Trailing twelve months (TTM) revenue — $X million (as of [date], per [source/filing]).
Latest quarter net income (loss) — $(Y) million (as of [date], per [source/filing]).
Cash and equivalents — $Z (as of [date], per balance sheet in 10‑Q).
Debt (total) — $D (as of [date], per 10‑Q/8‑K).
Market capitalization — $M (as of [date], per [market-data provider]).

Editors: replace placeholders above with precise, date-stamped numbers drawn from the company’s SEC filings and trusted data vendors.

Corporate governance and management

Board and executives: The company’s CEO and board members are listed in their proxy statements and periodic filings. For up-to-date names, biographies and any changes to management, consult the most recent 10‑K, DEF 14A (proxy), or company website.
Management disclosures: Small companies often disclose related-party transactions, insider sales/purchases, and management compensation in their filings; these items can materially affect investor views on governance.

Regulatory and legal matters

This section is intended to document material regulatory or legal events that could affect icct stock:

Trading halts: As reported by market-data outlets, trading halts occurred in 2025 pending material announcements; refer to the exchange/market notices and 8‑K filings for details.
Legal proceedings: If the company is party to litigation, settlements or enforcement actions, such matters are reported in periodic filings. Editors should list material suits, government inquiries or settlements with dates and filing references.

Always rely on SEC filings for the definitive account of regulatory and legal matters.

Risks and investor considerations

Investors and researchers should be aware of common risk factors associated with icct stock and small SaaS healthcare companies:

Low liquidity and high volatility: Micro‑cap stocks with thin float can exhibit rapid price swings and wide spreads.
Dilution risk: Small companies often rely on equity financings, convertible notes, or warrants that can dilute existing shareholders.
Negative earnings: Persistent net losses and limited cash reserves raise solvency and continuity risks.
Customer concentration: Dependence on a small set of customers can produce revenue volatility if contracts are lost.
Regulatory/compliance risk: Healthcare software is subject to HIPAA and other privacy and security standards; failure to comply could lead to fines, remediation costs, or reputational damage.
Market-data inconsistency: Different vendors may report different exchange venues, share counts, or market caps — always reference primary filings for verification.

No information in this article is financial advice. Readers should consult licensed professionals and the company’s filings for decisions.

Market coverage and analyst commentary

Coverage of icct stock is limited compared with larger public companies. Most commentary and data come from small‑cap research services, market-data aggregators, and local press items. Major national sell‑side analysts generally do not provide continuous coverage for micro‑cap tickers, so market price action may be driven by retail sentiment, press releases, or limited news flow.

Data vendors that include ICCT: MarketWatch, Barchart, GuruFocus, CNN Markets, MarketBeat, Reuters/Refinitiv, Trade‑Ideas, FinancialContent, StockAnalysis, Yahoo Finance. These providers aggregate price history, estimates, and basic ratios.
Analyst notes: Where present, analyst commentary tends to be brief and focused on corporate actions, financings, or regulatory filings.

Investor relations and filings

Official filings: The authoritative sources for financial and corporate disclosure are the company’s SEC filings (10‑K, 10‑Q, 8‑K, DEF 14A). These should be consulted for verified numbers, management commentary and the legal record.
Investor relations: Use the company’s investor relations materials to obtain press releases, archived presentations and official contact points for investor questions.

Editors should avoid relying solely on third‑party aggregators for legal or material facts; always link numbers to a filing or dated company disclosure.

References

The following sources were used to compile market and company summaries in this article. For precise figures and date-stamped values, consult the original filings and the sources below.

MarketWatch (ICCT stock page) — market quotes and corporate event summaries.
Barchart (ICCT price page) — historical price, corporate actions reporting.
GuruFocus (ICCT summary) — valuation metrics and financial summaries.
CNN Markets (ICCT quote) — basic quote and market-data snapshot.
MarketBeat (ICCT chart & price history) — alerts and corporate action notes.
Reuters / Refinitiv (ICCT price and volume metrics) — market notices and summaries.
Trade‑Ideas (ticker listings) — small‑cap ticker reporting.
FinancialContent (stock quoting feeds) — corporate quotes as presented in filings.
StockAnalysis (ICCT statistics & valuation metrics) — data aggregation.
Yahoo Finance (ICCT page) — price history and basic financials.
Company SEC filings and press releases — primary authoritative disclosures (10‑K, 10‑Q, 8‑K).

All dated statements in this article reference the above vendors; verify all time‑sensitive numbers against the company’s filings.

External links and data access

Company website and investor relations pages are primary places to confirm management commentary and press releases.
Real‑time quotes and charts are available from market‑data vendors, noting that many providers display delayed data for small‑cap tickers.

Editors: do not embed external hyperlinks in this entry. Use the company’s filings and vendor pages for sourcing.

Notes and guidance for editors

Time sensitivity: Market caps, share counts, prices and financial metrics change frequently. Always include the date when quoting numeric values.
Source priority: Prioritize SEC filings and company press releases for legal and financial facts. Use vendor snapshots only for convenience and not as primary evidence of legal facts.
Separation of fact and market data: Clearly mark numbers from filings vs. market-data vendor snapshots.
Style: Keep paragraphs short; use plain language and explain technical terms (e.g., reverse split, float, PDMP).